1. Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients. (April 2020) Authors: Florindez, Jorge; Trent, Jonathan Journal: American journal of clinical oncology Issue: Volume 43:Number 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 256 Single-agent zalifrelimab (anti-CTLA-4) shows clinical benefit in rare tumors – case report from phase 2 study (NCT03104699). (9th November 2020) Authors: Perez, Cesar; Wesolowski, Robert; Wilky, Breelyn; Feliu, Waldo Ortuzar; Zhang, Hong; Shapiro, Irina; Wijatyk, Anna; Kaleta, Remigiusz; Trent, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial. Issue 7 (July 2020) Authors: Heinrich, Michael C; Jones, Robin L; von Mehren, Margaret; Schöffski, Patrick; Serrano, César; Kang, Yoon-Koo; Cassier, Philippe A; Mir, Olivier; Eskens, Ferry; Tap, William D; Rutkowski, Piotr; Chawla, Sant P; Trent, Jonathan; Tugnait, Meera; Evans, Erica K; Lauz, Tamieka; Zhou, Teresa; Roche, M... Journal: Lancet oncology Issue: Volume 21:Issue 7(2020) Page Start: 935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oncological Outcomes in Patients with Appendicular Myxofibrosarcomas: A Retrospective Study. (28th November 2021) Authors: Lee, Yonghoon; Guertin, Michael P.; Summers, Spencer; Conway, Sheila A.; Al Maaieh, Mothasem; Yechieli, Raphael; Trent, Jonathan; Rosenberg, Andrew E.; Pretell-Mazzini, Juan Other Names: Sun Yingming Academic Editor. Journal: Journal of oncology Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study. Issue 28 (1st October 2021) Authors: Kang, Yoon-Koo; George, Suzanne; Jones, Robin L.; Rutkowski, Piotr; Shen, Lin; Mir, Olivier; Patel, Shreyaskumar; Zhou, Yongjian; von Mehren, Margaret; Hohenberger, Peter; Villalobos, Victor; Brahmi, Mehdi; Tap, William D.; Trent, Jonathan; Pantaleo, Maria A.; Schöffski, Patrick; He, Kevin; Hew, ... Journal: Journal of clinical oncology Issue: Volume 39:Issue 28(2021) Page Start: 3128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial. Issue 34 (1st December 2022) Authors: Bauer, Sebastian; Jones, Robin L.; Blay, Jean-Yves; Gelderblom, Hans; George, Suzanne; Schöffski, Patrick; von Mehren, Margaret; Zalcberg, John R.; Kang, Yoon-Koo; Razak, Albiruni Abdul; Trent, Jonathan; Attia, Steven; Le Cesne, Axel; Su, Ying; Meade, Julie; Wang, Tao; Sherman, Matthew L.; Ruiz-S... Journal: Journal of clinical oncology Issue: Volume 40:Issue 34(2022) Page Start: 3918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy. (1st February 2021) Authors: George, Suzanne; Jones, Robin L.; Bauer, Sebastian; Kang, Yoon‐Koo; Schöffski, Patrick; Eskens, Ferry; Mir, Olivier; Cassier, Phillipe A.; Serrano, Cesar; Tap, William D.; Trent, Jonathan; Rutkowski, Piotr; Patel, Shreyaskumar; Chawla, Sant P.; Meiri, Eval; Gordon, Michael; Zhou, Teresa; Roche, M... Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy. (1st February 2021) Authors: George, Suzanne; Jones, Robin L.; Bauer, Sebastian; Kang, Yoon‐Koo; Schöffski, Patrick; Eskens, Ferry; Mir, Olivier; Cassier, Phillipe A.; Serrano, Cesar; Tap, William D.; Trent, Jonathan; Rutkowski, Piotr; Patel, Shreyaskumar; Chawla, Sant P.; Meiri, Eval; Gordon, Michael; Zhou, Teresa; Roche, M... Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Research Spotlight: The future of biofuels: is it in the bag?. Issue 5 (September 2012) Authors: Trent, Jonathan; Wiley, Patrick; Tozzi, Sasha; McKuin, Brandi; Reinsch, Sigrid Journal: Biofuels Issue: Volume 3:Issue 5(2012) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors. (5th January 2021) Authors: Joseph, Cissimol P.; Abaricia, Sarah N.; Angelis, Michelle A.; Polson, Kathleen; Jones, Robin L.; Kang, Yoon‐Koo; Riedel, Richard F.; Schöffski, Patrick; Serrano, César; Trent, Jonathan; Tetzlaff, Eric D.; Si, Tuan Dong; Zhou, Teresa; Doyle, Ashley; Bauer, Sebastian; Roche, Maria; Havnaer, Tracy Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗